Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Industry / Manufacturing/  Glenmark partners Cyndea to develop soft-gelatin capsule
BackBack

Glenmark partners Cyndea to develop soft-gelatin capsule

Glenmark says it has entered into an agreement with Cyndea for developing generic soft-gelatin capsule formulations of certain pharmaceutical products

Cyndea will support Glenmark’s continued mission of providing important and cost-effective generic medicines to patients.Premium
Cyndea will support Glenmark’s continued mission of providing important and cost-effective generic medicines to patients.

New Delhi: Drug major Glenmark Pharmaceuticals on Wednesday said it has entered into an agreement with Cyndea Pharma for developing generic soft-gelatin capsule formulations of certain pharmaceutical products.

In a BSE filing, Glenmark Pharmaceuticals said it has “entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma S L, granting exclusive rights to use their technology for developing generic, soft-gelatin capsule formulations of certain pharmaceutical products".

Under this agreement, Glenmark receives exclusive rights to the US and Canada markets for these soft-gelatin formulations in exchange for sharing development costs and profits from future sales.

In addition, the agreement provides for the companies to add further soft-gelatin product candidates for development and commercialisation, as new branded softgelatin capsule-based drug products become available in the marketplace, Glenmark added.

Glenmark Pharmaceuticals president, North America, Global API Robert Matsuk said as many as 70% of small molecule pharmaceuticals are difficult for the body to absorb, which leads to challenges in developing effective oral formulations for these medicines.

“The use of soft-gelatin capsules have wide applications to improve absorption and bio-availability of these medicines. Accessing this formulation and manufacturing technology with our strategic partner Cyndea will support Glenmark’s continued mission of providing important and cost-effective generic medicines to patients," he added.

Shares of Glenmark Pharmaceuticals were trading up 1.84% at Rs704.35 on the BSE.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Industry News, Banking News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 19 Jul 2017, 02:15 PM IST
Next Story footLogo
Recommended For You
Manufacturing Stocks
₹557.550.52%
ITC
₹4280.13%
₹2,987.85-0.37%
₹152.852%
Switch to the Mint app for fast and personalized news - Get App